Grant: Collaborative Health Research Projects
McMaster University
$311,250.00
Developing Thermally Stable Dry Powder Vaccine Platforms Via Spray Drying Tailored for Inhalation Delivery
FY 2019-20
Summary
Innovations in vaccine development greatly benefit public health, by pursuing new andimproved biologics, and re-envisioning new delivery routes though changes in theirformulation and manufacture. The proposed research will advance recent progress made byan interdisciplinary team of scientists in designing new thermally stable vaccine platformstargeted against tuberculosis and influenza infection, where the temperature sensitivebiologics will be stabilized by encapsulation in suitable carriers, thereby removing thenecessity for costly and often unavailable refrigeration equipment in their storage andtransport. The proposed project brings together chemical engineering and biomedicalexpertise to understand and implement industrially relevant drying techniques that willproduce thermostable dry powder vaccines retaining their immune-boosting potency as seenin their original liquid form, yet now can be stored at room temperature for 3 months withoutloss in activity whereas liquid losses in potency occur in less than 1 week. Spray-drying thesevaccine powders under optimized conditions results in a product designed for delivery to thelung by inhalation, boosting their effectiveness against lung-borne infections like tuberculosisand influenza, while avoiding the complex logistics of re-constituting dried vaccines in liquidmedia prior to administration. The research will produce optimal examples of thermostabledry powder tuberculosis and influenza vaccines, relating their physical and biologicalproperties to engineering principles on particle formation and particle aerodynamics in thehuman respiratory system. The new knowledge will be transferred to appropriatepharmaceutical experts for the benefit of Canadas public health.
Program
Collaborative Health Research Projects
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
523837-2018
Name nom
Thompson, Michael
Department département
Chemical Engineering
Organization id
27
Institution établissement
McMaster University
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2019
Competition year année de concours
2018
Award amount
311250
Program id
CHRPJ
Program name en
Collaborative Health Research Projects
Program name fr
Projets de recherche concertée sur la santé
Group en
RESEARCH PARTNERSHIPS
Group fr
PARTENARIATS DE RECHERCHE
Committee code
360
Committee name en
Collaborative Health Research Projects Selection Panel
Committee name fr
Comité de sélection de projets de recherche concertée sur la santé
Area of application code
9999
Area of application group en
Not available
Area of application group fr
Non disponible
Area of application en
Not available
Area of application fr
Non disponible
Research subject code
1800
Research subject group en
Chemical engineering
Research subject group fr
Génie chimique
Research subject en
Chemical engineering
Research subject fr
Génie chimique
Installment
inst:2 - 3
Partie
2
Nb partie
3
Application title
Developing Thermally Stable Dry Powder Vaccine Platforms Via Spray Drying Tailored for Inhalation Delivery
Keyword
NSERC
Application summary
Innovations in vaccine development greatly benefit public health, by pursuing new andimproved biologics, and re-envisioning new delivery routes though changes in theirformulation and manufacture. The proposed research will advance recent progress made byan interdisciplinary team of scientists in designing new thermally stable vaccine platformstargeted against tuberculosis and influenza infection, where the temperature sensitivebiologics will be stabilized by encapsulation in suitable carriers, thereby removing thenecessity for costly and often unavailable refrigeration equipment in their storage andtransport. The proposed project brings together chemical engineering and biomedicalexpertise to understand and implement industrially relevant drying techniques that willproduce thermostable dry powder vaccines retaining their immune-boosting potency as seenin their original liquid form, yet now can be stored at room temperature for 3 months withoutloss in activity whereas liquid losses in potency occur in less than 1 week. Spray-drying thesevaccine powders under optimized conditions results in a product designed for delivery to thelung by inhalation, boosting their effectiveness against lung-borne infections like tuberculosisand influenza, while avoiding the complex logistics of re-constituting dried vaccines in liquidmedia prior to administration. The research will produce optimal examples of thermostabledry powder tuberculosis and influenza vaccines, relating their physical and biologicalproperties to engineering principles on particle formation and particle aerodynamics in thehuman respiratory system. The new knowledge will be transferred to appropriatepharmaceutical experts for the benefit of Canadas public health.